rs112602953

Variant summary

Our verdict is Pathogenic. The variant received 23 ACMG points: 23P and 0B. PS3PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_001613.4(ACTA2):​c.353G>A​(p.Arg118Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000287173: Experimental studies have shown that this missense change affects ACTA2 function (PMID:21288906).; SCV002557626: "This variant has strong functional evidence supporting abnormal protein function. Functional study using smooth muscle cells suggested that variant perturbs ACTA2 filament assembly or stability (PMID:17994018);"; SCV000710874: Studies on cultured smooth muscle cells (SMCs) derived from a heterozygous carrier of this variant suggest that this variant perturbs ACTA2 filament assembly or stability (Guo 2007).; SCV000738465: Functional studies suggest that this alteration may impact actin assembly (Guo DC et al. Nat. Genet., 2007 Dec;39:1488-93; Bergeron SE et al. J. Biol. Chem., 2011 Apr;286:11356-69).; SCV001733780: Functional studies in yeast and cultured smooth muscle cells have shown that this variant affects actin assembly or stability (PMID:17994018, 21288906).; SCV005203807: Experimental evidence in a yeast background suggests that this variant has significant impacts on actin polymerization and function (example, Bergeron_2011). PMID:23099432, 21288906, 19409525; SCV005900332: "Perturbation of ACTA2 filament assembly/stability has been demonstrated in smooth muscle cells and increased cellular proliferation in myofibroblasts of individuals with this variant (PMID:17994018, 19409525)."". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R118W) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

ACTA2
NM_001613.4 missense

Scores

14
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 7.91

Publications

23 publications found
Variant links:
Genes affected
ACTA2 (HGNC:130): (actin alpha 2, smooth muscle) This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, integrity, and intercellular signaling. The encoded protein is a smooth muscle actin that is involved in vascular contractility and blood pressure homeostasis. Mutations in this gene cause a variety of vascular diseases, such as thoracic aortic disease, coronary artery disease, stroke, and Moyamoya disease, as well as multisystemic smooth muscle dysfunction syndrome. [provided by RefSeq, Sep 2017]
STAMBPL1 (HGNC:24105): (STAM binding protein like 1) Predicted to enable Lys63-specific deubiquitinase activity and thiol-dependent deubiquitinase. Predicted to be involved in protein K63-linked deubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 23 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000287173: Experimental studies have shown that this missense change affects ACTA2 function (PMID: 21288906).; SCV002557626: "This variant has strong functional evidence supporting abnormal protein function. Functional study using smooth muscle cells suggested that variant perturbs ACTA2 filament assembly or stability (PMID: 17994018);"; SCV000710874: Studies on cultured smooth muscle cells (SMCs) derived from a heterozygous carrier of this variant suggest that this variant perturbs ACTA2 filament assembly or stability (Guo 2007).; SCV000738465: Functional studies suggest that this alteration may impact actin assembly (Guo DC et al. Nat. Genet., 2007 Dec;39:1488-93; Bergeron SE et al. J. Biol. Chem., 2011 Apr;286:11356-69).; SCV001733780: Functional studies in yeast and cultured smooth muscle cells have shown that this variant affects actin assembly or stability (PMID: 17994018, 21288906).; SCV005203807: Experimental evidence in a yeast background suggests that this variant has significant impacts on actin polymerization and function (example, Bergeron_2011). PMID: 23099432, 21288906, 19409525; SCV005900332: "Perturbation of ACTA2 filament assembly/stability has been demonstrated in smooth muscle cells and increased cellular proliferation in myofibroblasts of individuals with this variant (PMID: 17994018, 19409525)."
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 9 uncertain in NM_001613.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-88943814-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1053987.
PP2
Missense variant in the ACTA2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 27 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Trascript score misZ: 4.6117 (above the threshold of 3.09). GenCC associations: The gene is linked to Moyamoya disease 5, connective tissue disorder, multisystemic smooth muscle dysfunction syndrome, familial thoracic aortic aneurysm and aortic dissection, aortic aneurysm, familial thoracic 6.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.975
PP5
Variant 10-88943813-C-T is Pathogenic according to our data. Variant chr10-88943813-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 199670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001613.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTA2
NM_001613.4
MANE Select
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9NP_001604.1P62736
ACTA2
NM_001141945.3
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9NP_001135417.1D2JYH4
ACTA2
NM_001320855.2
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9NP_001307784.1P62736

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTA2
ENST00000224784.10
TSL:1 MANE Select
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9ENSP00000224784.6P62736
ACTA2
ENST00000713598.1
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9ENSP00000518894.1A0AAQ5BGG5
ACTA2
ENST00000415557.2
TSL:3
c.353G>Ap.Arg118Gln
missense
Exon 4 of 9ENSP00000396730.2P62736

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251034
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461514
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727074
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33464
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111714
Other (OTH)
AF:
0.00
AC:
0
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
Familial thoracic aortic aneurysm and aortic dissection (5)
2
-
-
Aortic aneurysm, familial thoracic 6 (2)
1
-
-
Aortic aneurysm, familial thoracic 6;C3151201:Multisystemic smooth muscle dysfunction syndrome;C3279690:Moyamoya disease 5 (1)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.55
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.86
D
Eigen
Pathogenic
0.98
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.55
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.1
M
PhyloP100
7.9
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-3.1
D
REVEL
Pathogenic
0.94
Sift4G
Uncertain
0.0070
D
Polyphen
0.94
P
Vest4
0.93
MutPred
0.90
Gain of ubiquitination at K115 (P = 0.0516)
MVP
1.0
ClinPred
0.97
D
GERP RS
5.9
Varity_R
0.90
gMVP
0.99
Mutation Taster
=9/91
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112602953; hg19: chr10-90703570; COSMIC: COSV56518008; COSMIC: COSV56518008; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.